ruthenium has been researched along with Leukemia in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 4 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ali, EA; Gamal, M; Guirguis, B; Khaled, RM; Mansour, AM; Mostafa, GAE; Radacki, K; Shehab, OR; Younes, Z | 1 |
| Amiri Rudbari, H; Askari, B; Bruno, G; Efferth, T; Micale, N; Schirmeister, T; Schwickert, K; Seo, EJ | 1 |
| Abreu, DC; Almeida, MAP; Batista, AA; de Castro Pereira, F; de Lima, AP; de Paula Silveira-Lacerda, E; de Souza Velozo-Sá, V; Mello-Andrade, F; Pires, WC | 1 |
| Ackermann, L; Almeida, RG; Costa, PMS; da Silva Júnior, EN; de Carvalho, RL; Fantuzzi, F; Jacob, C; Pessoa, C; Rogge, T; Rosa, LG | 1 |
| Bryszewska, M; de la Mata, FJ; Hołota, M; Ionov, M; Kubczak, M; Maroto, M; Michlewska, S; Ortega, P; Sanz Del Olmo, N; Shcharbin, D | 1 |
| Gobec, M; Gobec, S; Kljun, J; Mlinarič-Raščan, I; Sosič, I; Turel, I; Uršič, M | 1 |
| Bakalova, A; Ivanov, D; Momekov, G; Nikolova, A; Nikolova, K | 1 |
| Čermáková, E; Havelek, R; Kasilingam, V; Köhlerová, R; Muthná, D; Řezáčová, M; Stíbal, D; Süss-Fink, G; Tomšík, P | 1 |
8 other study(ies) available for ruthenium and Leukemia
| Article | Year |
|---|---|
Topics: Animals; Humans; Leukemia; Mice; Ruthenium | 2023 |
Ruthenium(ii) and palladium(ii) homo- and heterobimetallic complexes: synthesis, crystal structures, theoretical calculations and biological studies.
Topics: Alloys; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Coordination Complexes; Crystallization; Humans; Leukemia; Models, Molecular; Molecular Structure; Palladium; Ruthenium | 2019 |
Ru(II)-Based Amino Acid Complexes Show Promise for Leukemia Treatment: Cytotoxicity and Some Light on their Mechanism of Action.
Topics: Amino Acids; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Coordination Complexes; Humans; Leukemia; Ruthenium | 2020 |
Ruthenium(II)-Catalyzed Double Annulation of Quinones: Step-Economical Access to Valuable Bioactive Compounds.
Topics: Alkynes; Catalysis; Humans; Leukemia; Quinones; Ruthenium | 2020 |
Combined therapy of ruthenium dendrimers and anti-cancer drugs against human leukemic cells.
Topics: Anisotropy; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Dendrimers; Doxorubicin; Drug Combinations; Erythrocyte Membrane; Fluorescence; Humans; Leukemia; Methotrexate; Nanostructures; Ruthenium; Silanes | 2021 |
Structural characterization and biological evaluation of a clioquinol-ruthenium complex with copper-independent antileukaemic activity.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Clioquinol; Copper; Dimethyl Sulfoxide; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Humans; Inhibitory Concentration 50; Jurkat Cells; Leukemia; MCF-7 Cells; NF-kappa B; Oxyquinoline; Proteasome Endopeptidase Complex; Ruthenium | 2014 |
Novel Ru(III) Complexes with Some Benzothiazole Derivatives: Synthesis, Physicochemical and Pharmacological Investigations.
Topics: Antineoplastic Agents; Apoptosis; Benzothiazoles; Cell Line, Tumor; Cisplatin; Humans; Leukemia; Magnetic Resonance Spectroscopy; Ruthenium | 2015 |
In-vitro and in-vivo evaluation of the anticancer activity of diruthenium-2, a new trithiolato arene ruthenium complex [(η6-p-MeC6H4Pri)2Ru2(μ-S-p-C6H4OH)3]Cl.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Coordination Complexes; Drug Screening Assays, Antitumor; Female; HL-60 Cells; Humans; Leukemia; MCF-7 Cells; Mice; Ruthenium; Stomach Neoplasms; Xenograft Model Antitumor Assays | 2016 |